Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial (J-PROTECT): Rationale, design, and methodology

Taishiro Kishimoto, View ORCID ProfileShotaro Kinoshita, Shogyoku Bun, Yasunori Sato, Momoko Kitazawa, Toshiaki Kikuchi, Mitsuhiro Sado, Akihiro Takamiya, Masaru Mimura, Takashi Nakamae, Yoshinari Abe, Tetsufumi Kanazawa, Yasuo Kawabata, Hiroaki Tomita, Koichi Abe, Akitoyo Hishimoto, Takeshi Asami, Akira Suda, Yoshinori Watanabe, Toru Amagai, Kei Sakuma, Hisashi Kida, Michitaka Funayama, Hiroshi Kimura, Aiko Sato, Shuichiro Fujiwara, Kiichiro Nagao, Naoya Sugiyama, Maki Takamiya, Hideyuki Kodama, Takaharu Azekawa on behalf of the J-PROTECT collaborators
doi: https://doi.org/10.1101/2021.06.23.21259366
Taishiro Kishimoto
aHills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, #7F Roppongi Hills North Tower 6-2-31 Roppongi, Minato-ku, Tokyo 106-0032, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: taishiro-k{at}mti.biglobe.ne.jp
Shotaro Kinoshita
aHills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, #7F Roppongi Hills North Tower 6-2-31 Roppongi, Minato-ku, Tokyo 106-0032, Japan
bGraduate School of Medicine, International University of Health and Welfare, 4-1-26 Akasaka, Minato-ku, Tokyo, 107-8402, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Shotaro Kinoshita
Shogyoku Bun
cDepartment of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan
dSato Hospital, 948-1 Kunugizuka, Nanyo, Yamagata, 999-2221, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasunori Sato
eDepartment of Preventive Medicine and Public Health, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo, 160-8582, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Momoko Kitazawa
cDepartment of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshiaki Kikuchi
cDepartment of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitsuhiro Sado
cDepartment of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akihiro Takamiya
cDepartment of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masaru Mimura
cDepartment of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takashi Nakamae
fDepartment of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo, Kyoto, Kyoto, 602-8566, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshinari Abe
fDepartment of Psychiatry, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo, Kyoto, Kyoto, 602-8566, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tetsufumi Kanazawa
gDepartment of Neuropsychiatry, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686. Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasuo Kawabata
gDepartment of Neuropsychiatry, Osaka Medical and Pharmaceutical University, 2-7 Daigaku-machi, Takatsuki, Osaka, 569-8686. Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroaki Tomita
hDepartment of Psychiatry, Tohoku University Hospital, 1-1 Seiryo-Machi, Aoba-ku, Sendai, Miyagi, 980-8573, Japan
iDepartment of Psychiatry, Tohoku University Graduate School of Medicine, 1-1 Seiryo-Machi, Aoba-ku, Sendai, Miyagi, 980-8573, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koichi Abe
hDepartment of Psychiatry, Tohoku University Hospital, 1-1 Seiryo-Machi, Aoba-ku, Sendai, Miyagi, 980-8573, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akitoyo Hishimoto
jDepartment of Psychiatry, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takeshi Asami
jDepartment of Psychiatry, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akira Suda
jDepartment of Psychiatry, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshinori Watanabe
kHimorogi Psychiatric Institute, Ichigaya-Asukara Bldg. 1F2F, 2-31-3 Ichigayatamachi, Shinjuku, Tokyo 162-0843, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toru Amagai
lAmagai Mental Clinic, Kitami Bldg. 3F, 1-4-20 Kamiooka-nishi, Konan, Yokohama, Kanagawa, 233-0002, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kei Sakuma
mAsaka Hospital, 45 Kyotan, Sasagawa,Asakamachi, Koriyama, Fukushima, 963-0198, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hisashi Kida
cDepartment of Neuropsychiatry, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan
mAsaka Hospital, 45 Kyotan, Sasagawa,Asakamachi, Koriyama, Fukushima, 963-0198, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michitaka Funayama
nDepartment of Neuropsychiatry, Ashikaga Red Cross Hospital, 284-1 Yobe, Ashikaga, Tochigi, 326-0843, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Kimura
oDepartment of Psychiatry, Gakuji-kai Kimura Hospital, 6-19, Higashi Honcho, Chuo-ku, Chiba, Chiba, 260-0004, Japan
pDepartment of Psychiatry, School of Medicine, International University of Health and Welfare, 4-3, Kozunomori, Narita, Chiba, 286-8686, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aiko Sato
pDepartment of Psychiatry, School of Medicine, International University of Health and Welfare, 4-3, Kozunomori, Narita, Chiba, 286-8686, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuichiro Fujiwara
qKanazawabunko Yell Clinic, KANAZAWA BUNKO PARK HOMES 102, Kamariyahigashi, Kanazawa, Yokohama, Kanagawa, 236-0042, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kiichiro Nagao
rNeyagawa Sanatoriumu, 2370-6 Neyagawakoen, Neyagawa, Osaka, Osaka, 572-0854, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoya Sugiyama
sNumazu Chuo Hospital, 24-1 Nakase-cho, Numazu, Shizuoka, 410-8575, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maki Takamiya
tTakamiya Hospital, 1931 Omachikou, Yoshimura, Miyazaki, Miyazaki, 880-0841, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideyuki Kodama
tTakamiya Hospital, 1931 Omachikou, Yoshimura, Miyazaki, Miyazaki, 880-0841, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takaharu Azekawa
uShioiri Mental Clinic, 2-7-1 Shioiri, Yokosuka, Kanagawa, 238-0042, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Introduction The COVID-19 pandemic has had a profound impact on the mental health of people around the world. Anxiety related to infection, stress and stigma caused by the forced changes in daily life have reportedly increased the incidence and symptoms of depression, anxiety disorder and obsessive-compulsive disorder. Under such circumstances, telepsychiatry is gaining importance and attracting a great deal of attention. However, few large pragmatic clinical trials on the use of telepsychiatry targeting multiple psychiatric disorders have been conducted to date.

Methods The targeted study cohort will consist of adults (>18 years) who meet the DSM-5 diagnostic criteria for either (1) depressive disorders, (2) anxiety disorders, or (3) obsessive-compulsive and related disorders. Patients will be assigned in a 1:1 ratio to either a “telepsychiatry group” (at least 50% of visits to be conducted using telemedicine, with at least one face-to-face treatment [FTF] every six months) or an “FTF group” (all visits to be conducted FTF, with no telemedicine). Both groups will receive the usual treatment covered by public medical insurance. The study will utilize a master protocol design in that there will be primary and secondary outcomes for the entire group regardless of diagnosis, as well as the outcomes for each individual disorder group.

Discussion This study will be a non-inferiority trial to test that the treatment effect of telepsychiatry is not inferior to that of FTF alone. This study will provide useful insights into the effect of the COVID-19 pandemic on the practice of psychiatry.

Trial Registration jRCT1030210037, Japan Registry of Clinical Trials (jRCT)

Competing Interest Statement

T. Kishimoto: Research grant funding, Micin.

T. Nakamae: Provided with a telemedicine system, Medley.

Y. Abe: Provided with a telemedicine system, Medley.

Clinical Trial

jRCT1030210037

Funding Statement

This research is supported by the Japan Agency for Medical Research and Development (AMED) under Grant Number JP21dk0307098.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Institutional Review Board of the National Center of Neurology and Psychiatry and the participating medical facilities.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Due to the nature of this research, participants of this study did not agree for their data to be shared publicly, so supporting data is not available.

  • Abbreviations

    COVID-19
    the 2019 novel coronavirus disease
    J-PROTECT
    Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial
    DSM-5
    Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition
    FTF
    face-to-face treatment
    jRCT
    Japan Registry of Clinical Trials
    OCD
    obsessive–compulsive disorder
    SF36MCS
    MOS36-Item Short-Form Health Survey Mental Component Summary
    SF36
    MOS 36-Item Short-Form Health Survey
    WAI
    Working Alliance Inventory
    CSQ
    Client Satisfaction Questionnaire
    EQ-5D
    EuroQol 5 Dimension
    HAMD
    Hamilton Depression Rating Scale
    HAMA
    Hamilton Anxiety Rating Scale
    YBOCS
    Yale-Brown Obsessive Compulsive Scale
    EDC
    electronic data capture
    ePRO
    electronic patient-reported outcome
    QOL
    quality of life
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted June 29, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial (J-PROTECT): Rationale, design, and methodology
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial (J-PROTECT): Rationale, design, and methodology
    Taishiro Kishimoto, Shotaro Kinoshita, Shogyoku Bun, Yasunori Sato, Momoko Kitazawa, Toshiaki Kikuchi, Mitsuhiro Sado, Akihiro Takamiya, Masaru Mimura, Takashi Nakamae, Yoshinari Abe, Tetsufumi Kanazawa, Yasuo Kawabata, Hiroaki Tomita, Koichi Abe, Akitoyo Hishimoto, Takeshi Asami, Akira Suda, Yoshinori Watanabe, Toru Amagai, Kei Sakuma, Hisashi Kida, Michitaka Funayama, Hiroshi Kimura, Aiko Sato, Shuichiro Fujiwara, Kiichiro Nagao, Naoya Sugiyama, Maki Takamiya, Hideyuki Kodama, Takaharu Azekawa
    medRxiv 2021.06.23.21259366; doi: https://doi.org/10.1101/2021.06.23.21259366
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial (J-PROTECT): Rationale, design, and methodology
    Taishiro Kishimoto, Shotaro Kinoshita, Shogyoku Bun, Yasunori Sato, Momoko Kitazawa, Toshiaki Kikuchi, Mitsuhiro Sado, Akihiro Takamiya, Masaru Mimura, Takashi Nakamae, Yoshinari Abe, Tetsufumi Kanazawa, Yasuo Kawabata, Hiroaki Tomita, Koichi Abe, Akitoyo Hishimoto, Takeshi Asami, Akira Suda, Yoshinori Watanabe, Toru Amagai, Kei Sakuma, Hisashi Kida, Michitaka Funayama, Hiroshi Kimura, Aiko Sato, Shuichiro Fujiwara, Kiichiro Nagao, Naoya Sugiyama, Maki Takamiya, Hideyuki Kodama, Takaharu Azekawa
    medRxiv 2021.06.23.21259366; doi: https://doi.org/10.1101/2021.06.23.21259366

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Psychiatry and Clinical Psychology
    Subject Areas
    All Articles
    • Addiction Medicine (430)
    • Allergy and Immunology (756)
    • Anesthesia (221)
    • Cardiovascular Medicine (3298)
    • Dentistry and Oral Medicine (365)
    • Dermatology (280)
    • Emergency Medicine (479)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1173)
    • Epidemiology (13383)
    • Forensic Medicine (19)
    • Gastroenterology (899)
    • Genetic and Genomic Medicine (5157)
    • Geriatric Medicine (482)
    • Health Economics (783)
    • Health Informatics (3273)
    • Health Policy (1143)
    • Health Systems and Quality Improvement (1193)
    • Hematology (432)
    • HIV/AIDS (1019)
    • Infectious Diseases (except HIV/AIDS) (14636)
    • Intensive Care and Critical Care Medicine (913)
    • Medical Education (478)
    • Medical Ethics (127)
    • Nephrology (525)
    • Neurology (4930)
    • Nursing (262)
    • Nutrition (730)
    • Obstetrics and Gynecology (885)
    • Occupational and Environmental Health (795)
    • Oncology (2524)
    • Ophthalmology (727)
    • Orthopedics (282)
    • Otolaryngology (347)
    • Pain Medicine (323)
    • Palliative Medicine (90)
    • Pathology (544)
    • Pediatrics (1302)
    • Pharmacology and Therapeutics (551)
    • Primary Care Research (557)
    • Psychiatry and Clinical Psychology (4218)
    • Public and Global Health (7511)
    • Radiology and Imaging (1708)
    • Rehabilitation Medicine and Physical Therapy (1016)
    • Respiratory Medicine (980)
    • Rheumatology (480)
    • Sexual and Reproductive Health (498)
    • Sports Medicine (424)
    • Surgery (549)
    • Toxicology (72)
    • Transplantation (236)
    • Urology (205)